Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy

Betsy T. Kren, Gretchen M. Unger, Md J. Abedin, Rachel I. Vogel, Christine M. Henzler, Khalil Ahmed, Janeen H. Trembley

Research output: Contribution to journal › Article › peer-review

50 Scopus citations

Fingerprint

Dive into the research topics of 'Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences